Patronus AI unveiled “Generative Simulators,” adaptive “practice worlds” that replace static benchmarks with dynamic ...
You tell it to clean up a deployment, and it might literally delete a production environment because it doesn’t understand intent the way a human does.” He adds: “This excessive agency problem is ...
Skills—a capability that allows users to teach Claude repeatable workflows—was introduced in October, and now Anthropic is ...
The MM+M editorial team was heartened by the progress made treating Alzheimer’s disease, the case of KJ Muldoon and ...
Wellbeing Magazine on MSN
How to cope with holiday stress and burnout
For many, the festive season conjures images of cosy gatherings, twinkling lights and joyful celebration. But beneath the ...
Digital archive and viralised wounds Imagine two situations. First, in a pala gaan or bichar gaan, a person utters a blasphemous phrase to refute it. Second, someone has written or said something ...
Telling ChatGPT to fact-check a random answer before solving an actual problem makes it think harder, and get the answer right more often – even if the earlier 'random' answer has nothing to do with ...
The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation ...
Primary school students have been reading TikTok sensation Icebreaker, an enemies-to-lovers romance about a figure skater and ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results